feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Netherlands faces Lithuania in qualifier

trending

Northern Ireland faces Luxembourg

trending

ADOR protects NewJeans' rights

trending

Mumbai CNG supply disruption

trending

Lava Agni 4 launch date

trending

Aadhar update simplifies key details

trending

PM Kisan eKYC mandatory

trending

WPL Auction 2026: Date confirmed

trending

Rajasthan police busts Mephedrone lab

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Weight Loss Drugs Linked to Spike in Haemorrhoids

Weight Loss Drugs Linked to Spike in Haemorrhoids

16 Nov

•

Summary

  • 41% rise in haemorrhoid cases in past 6 months
  • GLP-1 drugs like Mounjaro and Ozempic causing constipation and piles
  • Straining from weight training also exacerbating the issue
Weight Loss Drugs Linked to Spike in Haemorrhoids

According to health experts, the growing popularity of weight loss drugs like Mounjaro and Ozempic has led to a significant spike in haemorrhoid cases over the past year. Dr. Ross Perry, founder of Cosmedics Skin Clinics, reports a 41% rise in patients seeking treatment for piles in the last 6 months alone, with many of them taking GLP-1 medications.

The issue stems from how these weight loss drugs slow down digestion and cause constipation, leading to straining and the development of haemorrhoids. In addition, some patients are hitting the gym to counter muscle loss from the drugs, but the weight training can also exacerbate the problem.

Experts advise that while weight loss drugs are generally well-tolerated, the increase in dosage can trigger unpleasant side effects like haemorrhoids. They recommend seeking medical help if the discomfort becomes debilitating, and taking steps like increasing fibre intake, staying hydrated, and using over-the-counter creams to manage the condition.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The weight loss drugs Mounjaro and Ozempic are causing a spike in haemorrhoid cases, as they slow down digestion and lead to constipation, which can result in straining and the development of piles.
Many patients taking these weight loss drugs are also hitting the gym to counter muscle loss, but the straining involved in weight training can exacerbate their haemorrhoid issues.
Experts advise seeking medical help if the haemorrhoid discomfort becomes debilitating, and taking steps like increasing fibre intake, staying hydrated, and using over-the-counter creams to manage the condition.

Read more news on

Healthside-arrow

You may also like

Newcomers in Hamilton Empowered to Advocate for Their Needs

1 day ago • 4 reads

Aspirin: The Lifesaving Remedy for Heart Attacks

15 Nov • 9 reads

article image

Women's Hidden Sleep Crisis: Undiagnosed Apnea Risks Heart Damage

14 Nov • 4 reads

article image

Cutting-Edge Gene Therapy Slashes Cholesterol by 50% with Single Dose

11 Nov • 24 reads

article image

Mayo Clinic's Stem Cell Patch Aims to Revolutionize Heart Failure Treatment

10 Nov • 44 reads